share_log

Marker Therapeutics Shares Are Trading Higher After the Company Announced It Won a $9.5 Million Grant to Study Pancreatic Cancer Therapy.

Benzinga ·  Dec 17 08:35
Marker Therapeutics Shares Are Trading Higher After the Company Announced It Won a $9.5 Million Grant to Study Pancreatic Cancer Therapy.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment